FDA Clearance Tracker · P160043
RESOLUTE ONYX ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 28, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Apr 28, 2017
Approved
Time to decision
213 days
Received Sep 27, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P160043
- Device name
- RESOLUTE ONYX ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM
- Applicant
- Medtronic Vascular
- Applicant location
- Santa Rosa, CA
- Received
- Sep 27, 2016
- Decided
- Apr 28, 2017
- Decision
- Approved
- Supplements
- 88 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Coronary drug-eluting stent (NIQ)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the Resolute Onyx Zotarolimus-Eluting Coronary Stent System. This device is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de novo lesions of length less than or equal to 35 mm in native coronary arteries with reference vessel diameters of 2.25 mm to 5.0 mm.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIQ. The earliest in FDA's data is P020026, decided Apr 24, 2003.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232570 · Decided Oct 24, 2023 · 61 days after receipt
Device type: Wire, Guide, Catheter (DQX) · Cardiology
K232190 · Decided Aug 22, 2023 · 29 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
K230156 · Decided Jun 30, 2023 · 162 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.